{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T10:54:44Z","timestamp":1792407284476,"version":"4.4.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Biol Lett"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is associated with a high mortality rate. The majority of deaths in this disease are caused by ARDS (acute respiratory distress syndrome) followed by cytokine storm and coagulation complications. Although alterations in the level of the number of coagulation factors have been detected in samples from COVID-19 patients, the direct molecular mechanism which has been involved in this pathologic process has not been explored yet. The PI3K\/AKT signaling pathway is an intracellular pathway which plays a central role in cell survival. Also, in recent years the association between this pathway and coagulopathies has been well clarified. Therefore, based on the evidence on over-activity of the PI3K\/AKT signaling pathway in SARS-CoV-2 infection, in the current review, the probable role of this cellular pathway as a therapeutic target for the prevention of coagulation complications in patients with COVID-19 is discussed.<\/jats:p>","DOI":"10.1186\/s11658-022-00308-w","type":"journal-article","created":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T16:02:50Z","timestamp":1641916970000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["The probable role and therapeutic potential of the PI3K\/AKT signaling pathway in SARS-CoV-2 induced coagulopathy"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4280-0378","authenticated-orcid":false,"given":"Mohammad Rafi","family":"Khezri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Varzandeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5672-9202","authenticated-orcid":false,"given":"Morteza","family":"Ghasemnejad-Berenji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,11]]},"reference":[{"key":"308_CR1","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.3389\/fimmu.2020.01206","volume":"11","author":"A Girija","year":"2020","unstructured":"Girija A, Shankar EM, Larsson M. Could SARS-CoV-2-induced hyperinflammation magnify the severity of coronavirus disease (CoViD-19) leading to acute respiratory distress syndrome? Front Immunol. 2020;11:1206.","journal-title":"Front Immunol"},{"issue":"6","key":"308_CR2","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1007\/s13577-021-00605-0","volume":"34","author":"MR Khezri","year":"2021","unstructured":"Khezri MR, Ghasemnejad-Berenji M. Neurological effects of elevated levels of angiotensin II in COVID-19 patients. Hum Cell. 2021;34(6):1941\u20132.","journal-title":"Hum Cell"},{"issue":"23","key":"308_CR3","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1056\/NEJMc2008597","volume":"382","author":"J Helms","year":"2020","unstructured":"Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020;382(23):2268\u201370.","journal-title":"N Engl J Med"},{"issue":"7","key":"308_CR4","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1515\/cclm-2020-0188","volume":"58","author":"H Han","year":"2020","unstructured":"Han H, Yang L, Liu R, Liu F, Wu K-L, Li J, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med (CCLM). 2020;58(7):1116\u201320.","journal-title":"Clin Chem Lab Med (CCLM)."},{"key":"308_CR5","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1515\/cclm-2021-0108","volume":"59","author":"E Campello","year":"2021","unstructured":"Campello E, Bulato C, Spiezia L, Boscolo A, Poletto F, Cola M, et al. Thrombin generation in patients with COVID-19 with and without thromboprophylaxis. Clin Chem Lab Med (CCLM). 2021;59:1323.","journal-title":"Clin Chem Lab Med (CCLM)."},{"issue":"1","key":"308_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13613-021-00899-1","volume":"11","author":"N Yatim","year":"2021","unstructured":"Yatim N, Boussier J, Chocron R, Hadjadj J, Philippe A, Gendron N, et al. Platelet activation in critically ill COVID-19 patients. Ann Intensive Care. 2021;11(1):1\u201312.","journal-title":"Ann Intensive Care"},{"issue":"4","key":"308_CR7","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/jth.14768","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844\u20137.","journal-title":"J Thromb Haemost"},{"key":"308_CR8","doi-asserted-by":"crossref","unstructured":"Allegra A, Innao V, Allegra AG, Musolino C. Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies. Ann Hematol. 2020; 1\u201313.","DOI":"10.1007\/s00277-020-04182-4"},{"issue":"6","key":"308_CR9","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3109\/07853890.2014.912836","volume":"46","author":"M Martini","year":"2014","unstructured":"Martini M, De Santis MC, Braccini L, Gulluni F, Hirsch E. PI3K\/AKT signaling pathway and cancer: an updated review. Ann Med. 2014;46(6):372\u201383.","journal-title":"Ann Med"},{"issue":"4","key":"308_CR10","doi-asserted-by":"publisher","first-page":"564","DOI":"10.2478\/s11658-011-0023-y","volume":"16","author":"J Huang","year":"2011","unstructured":"Huang J, Xia C, Zheng X, Yi T, Wang X, Song G, et al. 17\u03b2-Estradiol promotes cell proliferation in rat osteoarthritis model chondrocytes via PI3K\/Akt pathway. Cell Mol Biol Lett. 2011;16(4):564\u201375.","journal-title":"Cell Mol Biol Lett"},{"issue":"9","key":"308_CR11","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/aor.13465","volume":"43","author":"Z Chen","year":"2019","unstructured":"Chen Z, Li T, Kareem K, Tran D, Griffith BP, Wu ZJ. The role of PI3K\/Akt signaling pathway in non-physiological shear stress-induced platelet activation. Artif Organs. 2019;43(9):897\u2013908.","journal-title":"Artif Organs"},{"key":"308_CR12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jbior.2015.06.001","volume":"59","author":"GF Guidetti","year":"2015","unstructured":"Guidetti GF, Canobbio I, Torti M. PI3K\/Akt in platelet integrin signaling and implications in thrombosis. Adv Biol Regul. 2015;59:36\u201352.","journal-title":"Adv Biol Regul"},{"key":"308_CR13","unstructured":"Pelzl L, Singh A, Funk J, Witzemann A, Zlamal J, Marini I, et al. Platelet activation via PI3K\/AKT signaling pathway in COVID-19. Res Pract Thromb Haemostasis. 2021."},{"issue":"2","key":"308_CR14","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1128\/AAC.03659-14","volume":"59","author":"J Kindrachuk","year":"2015","unstructured":"Kindrachuk J, Ork B, Mazur S, Holbrook MR, Frieman MB, Traynor D, et al. Antiviral potential of ERK\/MAPK and PI3K\/AKT\/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis. Antimicrob Agents Chemother. 2015;59(2):1088\u201399.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"308_CR15","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.bbrc.2006.06.086","volume":"347","author":"T Mizutani","year":"2006","unstructured":"Mizutani T, Fukushi S, Ishii K, Sasaki Y, Kenri T, Saijo M, et al. Mechanisms of establishment of persistent SARS-CoV-infected cells. Biochem Biophys Res Commun. 2006;347(1):261\u20135.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1\u20132","key":"308_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bbadis.2005.04.004","volume":"1741","author":"T Mizutani","year":"2005","unstructured":"Mizutani T, Fukushi S, Saijo M, Kurane I, Morikawa S. JNK and PI3k\/Akt signaling pathways are required for establishing persistent SARS-CoV infection in Vero E6 cells. Biochimica et Biophysica Acta BBA Mol Basis Dis. 2005;1741(1\u20132):4\u201310.","journal-title":"Biochimica et Biophysica Acta BBA Mol Basis Dis."},{"issue":"9","key":"308_CR17","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.7150\/ijbs.57810","volume":"17","author":"F Sun","year":"2021","unstructured":"Sun F, Mu C, Kwok HF, Xu J, Wu Y, Liu W, et al. Capivasertib restricts SARS-CoV-2 cellular entry: a potential clinical application for COVID-19. Int J Biol Sci. 2021;17(9):2348.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"308_CR18","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1080\/22221751.2020.1799723","volume":"9","author":"S Appelberg","year":"2020","unstructured":"Appelberg S, Gupta S, Svensson Akusj\u00e4rvi S, Ambikan AT, Mikaeloff F, Saccon E, et al. Dysregulation in Akt\/mTOR\/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells. Emerg Microbes Infect. 2020;9(1):1748\u201360.","journal-title":"Emerg Microbes Infect"},{"key":"308_CR19","doi-asserted-by":"crossref","unstructured":"Garcia Jr G, Sharma A, Ramaiah A, Sen C, Kohn DB, Gomperts BN, et al. Antiviral drug screen of kinase inhibitors identifies cellular signaling pathways critical for SARS-CoV-2 replication. SSRN 3682004. 2020.","DOI":"10.2139\/ssrn.3682004"},{"issue":"3","key":"308_CR20","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/j.1538-7836.2009.03716.x","volume":"8","author":"GJ Pennings","year":"2010","unstructured":"Pennings GJ, Yong AS, Kritharides L. Expression of EMMPRIN (CD147) on circulating platelets in vivo. J Thromb Haemost. 2010;8(3):472\u201381.","journal-title":"J Thromb Haemost"},{"issue":"6","key":"308_CR21","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1161\/ATVBAHA.120.315698","volume":"41","author":"C Langnau","year":"2021","unstructured":"Langnau C, Rohlfing AK, Gekeler S, G\u00fcnter M, P\u00f6schel S, Petersen-Uribe \u00c1, et al. Platelet activation and plasma levels of furin are associated with prognosis of patients with coronary artery disease and COVID-19. Arterioscler Thromb Vasc Biol. 2021;41(6):2080\u201396.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"308_CR22","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1161\/ATVBAHA.114.305112","volume":"35","author":"P Seizer","year":"2015","unstructured":"Seizer P, Ungern-Sternberg SN, Sch\u00f6nberger T, Borst O, M\u00fcnzer P, Schmidt EM, et al. Extracellular cyclophilin A activates platelets via EMMPRIN (CD147) and PI3K\/Akt signaling, which promotes platelet adhesion and thrombus formation in vitro and in vivo. Arterioscler Thromb Vasc Biol. 2015;35(3):655\u201363.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"308_CR23","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.3390\/cancers12092686","volume":"12","author":"Z He","year":"2020","unstructured":"He Z, Khatib AM, Creemers JWM. Loss of proprotein convertase furin in mammary gland impairs proIGF1R and proIR processing and suppresses tumorigenesis in triple negative breast cancer. Cancers (Basel). 2020;12(9):2686.","journal-title":"Cancers (Basel)."},{"key":"308_CR24","doi-asserted-by":"publisher","first-page":"100306","DOI":"10.1016\/j.jbc.2021.100306","volume":"296","author":"A Bayati","year":"2021","unstructured":"Bayati A, Kumar R, Francis V, McPherson PS. SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis. J Biol Chem. 2021;296:100306.","journal-title":"J Biol Chem"},{"key":"308_CR25","doi-asserted-by":"publisher","first-page":"886","DOI":"10.3389\/fmicb.2015.00886","volume":"6","author":"J Tian","year":"2015","unstructured":"Tian J, Zhang X, Wu H, Liu C, Li Z, Hu X, et al. Blocking the PI3K\/AKT pathway enhances mammalian reovirus replication by repressing IFN-stimulated genes. Front Microbiol. 2015;6:886.","journal-title":"Front Microbiol"},{"key":"308_CR26","doi-asserted-by":"publisher","first-page":"174191","DOI":"10.1016\/j.ejphar.2021.174191","volume":"905","author":"MR Khezri","year":"2021","unstructured":"Khezri MR, Zolbanin NM, Ghasemnejad-Berenji M, Jafari R. Azithromycin: immunomodulatory and antiviral properties for SARS-CoV-2 infection. Eur J Pharmacol. 2021;905:174191.","journal-title":"Eur J Pharmacol"},{"key":"308_CR27","doi-asserted-by":"crossref","unstructured":"Malgotra V, Sharma V. 2-Deoxy-d-glucose inhibits replication of novel coronavirus (SARS-CoV-2) with adverse effects on host cell metabolism. 2021.","DOI":"10.20944\/preprints202106.0333.v1"},{"key":"308_CR28","doi-asserted-by":"crossref","unstructured":"Bartolini D, Stabile AM, Vacca C, Pistilli A, Rende M, Gioiello A, et al. Endoplasmic reticulum stress and NF\u2010kB activation in SARS\u2010CoV\u20102 infected cells and their response to antiviral therapy. IUBMB Life. 2021.","DOI":"10.1002\/iub.2537"},{"issue":"2","key":"308_CR29","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1007\/s13577-021-00484-5","volume":"34","author":"MR Khezri","year":"2021","unstructured":"Khezri MR. PI3K\/AKT signaling pathway: a possible target for adjuvant therapy in COVID-19. Hum Cell. 2021;34(2):700\u20131.","journal-title":"Hum Cell"},{"issue":"9","key":"308_CR30","doi-asserted-by":"publisher","first-page":"200160","DOI":"10.1098\/rsob.200160","volume":"10","author":"A Fara","year":"2020","unstructured":"Fara A, Mitrev Z, Rosalia RA, Assas BM. Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines. Open Biol. 2020;10(9):200160.","journal-title":"Open Biol"},{"issue":"1","key":"308_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12964-018-0268-4","volume":"16","author":"MM Zegeye","year":"2018","unstructured":"Zegeye MM, Lindkvist M, F\u00e4lker K, Kumawat AK, Paramel G, Greneg\u00e5rd M, et al. Activation of the JAK\/STAT3 and PI3K\/AKT pathways are crucial for IL-6 trans-signaling-mediated pro-inflammatory response in human vascular endothelial cells. Cell Commun Signal. 2018;16(1):1\u201310.","journal-title":"Cell Commun Signal"},{"issue":"8","key":"308_CR32","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1080\/08941939.2019.1705941","volume":"34","author":"X Bai","year":"2021","unstructured":"Bai X, Guo X, Zhang F, Zheng L, Ding W, Yang S. Resveratrol combined with 17 \u03b2-estradiol prevents IL-1 \u03b2 induced apoptosis in human nucleus pulposus via the PI3K\/AKT\/Mtor and PI3K\/AKT\/GSK-3 \u03b2 pathway. J Invest Surg. 2021;34(8):904\u201311.","journal-title":"J Invest Surg"},{"issue":"3","key":"308_CR33","doi-asserted-by":"publisher","first-page":"L799","DOI":"10.1152\/ajplung.00311.2006","volume":"292","author":"C-W Lee","year":"2007","unstructured":"Lee C-W, Lin C-C, Lin W-N, Liang K-C, Luo S-F, Wu C-B, et al. TNF-\u03b1 induces MMP-9 expression via activation of Src\/EGFR, PDGFR\/PI3K\/Akt cascade and promotion of NF-\u03baB\/p300 binding in human tracheal smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2007;292(3):L799\u2013812.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"308_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms7535","volume":"6","author":"JK Mountford","year":"2015","unstructured":"Mountford JK, Petitjean C, Putra HWK, McCafferty JA, Setiabakti NM, Lee H, et al. The class II PI 3-kinase, PI3KC2\u03b1, links platelet internal membrane structure to shear-dependent adhesive function. Nat Commun. 2015;6(1):1\u201314.","journal-title":"Nat Commun"},{"issue":"13","key":"308_CR35","first-page":"4243","volume":"110","author":"I Hers","year":"2007","unstructured":"Hers I. Insulin-like growth factor-1 potentiates platelet activation via the IRS\/PI3K\u03b1 pathway. Blood J Am Soc Hematol. 2007;110(13):4243\u201352.","journal-title":"Blood J Am Soc Hematol"},{"issue":"13","key":"308_CR36","first-page":"4206","volume":"110","author":"S Kim","year":"2007","unstructured":"Kim S, Garcia A, Jackson SP, Kunapuli SP. Insulin-like growth factor-1 regulates platelet activation through PI3-K\u03b1 isoform. Blood J Am Soc Hematol. 2007;110(13):4206\u201313.","journal-title":"Blood J Am Soc Hematol"},{"issue":"8","key":"308_CR37","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1161\/ATVBAHA.114.303954","volume":"34","author":"TA Blair","year":"2014","unstructured":"Blair TA, Moore SF, Williams CM, Poole AW, Vanhaesebroeck B, Hers I. Phosphoinositide 3-kinases p110\u03b1 and p110\u03b2 have differential roles in insulin-like growth factor-1\u2013mediated Akt phosphorylation and platelet priming. Arterioscler Thromb Vasc Biol. 2014;34(8):1681\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"308_CR38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cellsig.2018.05.005","volume":"50","author":"T Blair","year":"2018","unstructured":"Blair T, Moore S, Walsh T, Hutchinson J, Durrant T, Anderson K, et al. Phosphoinositide 3-kinase p110\u03b1 negatively regulates thrombopoietin-mediated platelet activation and thrombus formation. Cell Signal. 2018;50:111\u201320.","journal-title":"Cell Signal"},{"key":"308_CR39","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ejphar.2014.10.059","volume":"746","author":"H-Z Hao","year":"2015","unstructured":"Hao H-Z, He A-D, Wang D-C, Yin Z, Zhou Y-J, Liu G, et al. Antiplatelet activity of loureirin A by attenuating Akt phosphorylation: in vitro studies. Eur J Pharmacol. 2015;746:63\u20139.","journal-title":"Eur J Pharmacol"},{"issue":"18","key":"308_CR40","first-page":"3718","volume":"121","author":"X Chen","year":"2013","unstructured":"Chen X, Zhang Y, Wang Y, Li D, Zhang L, Wang K, et al. PDK1 regulates platelet activation and arterial thrombosis. Blood J Am Soc Hematol. 2013;121(18):3718\u201326.","journal-title":"Blood J Am Soc Hematol"},{"issue":"6","key":"308_CR41","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1074\/jbc.M112.429936","volume":"288","author":"SF Moore","year":"2013","unstructured":"Moore SF, van den Bosch MT, Hunter RW, Sakamoto K, Poole AW, Hers I. Dual regulation of glycogen synthase kinase 3 (GSK3) \u03b1\/\u03b2 by protein kinase C (PKC) \u03b1 and Akt promotes thrombin-mediated integrin \u03b1IIb\u03b23 activation and granule secretion in platelets. J Biol Chem. 2013;288(6):3918\u201328.","journal-title":"J Biol Chem"},{"issue":"6","key":"308_CR42","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1182\/blood-2003-10-3428","volume":"104","author":"J Chen","year":"2004","unstructured":"Chen J, De S, Damron DS, Chen WS, Hay N, Byzova TV. Impaired platelet responses to thrombin and collagen in AKT-1\u2013deficient mice. Blood. 2004;104(6):1703\u201310.","journal-title":"Blood"},{"issue":"3","key":"308_CR43","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1172\/JCI200420267","volume":"113","author":"D Woulfe","year":"2004","unstructured":"Woulfe D, Jiang H, Morgans A, Monks R, Birnbaum M, Brass LF. Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2. J Clin Investig. 2004;113(3):441\u201350.","journal-title":"J Clin Investig"},{"issue":"15","key":"308_CR44","first-page":"4215","volume":"118","author":"KA O'Brien","year":"2011","unstructured":"O\u2019Brien KA, Stojanovic-Terpo A, Hay N, Du X. An important role for Akt3 in platelet activation and thrombosis. Blood J Am Soc Hematol. 2011;118(15):4215\u201323.","journal-title":"Blood J Am Soc Hematol"},{"issue":"9","key":"308_CR45","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1161\/ATVBAHA.112.254680","volume":"32","author":"KA O\u2019Brien","year":"2012","unstructured":"O\u2019Brien KA, Gartner TK, Hay N, Du X. ADP-stimulated activation of Akt during integrin outside-in signaling promotes platelet spreading by inhibiting glycogen synthase kinase-3\u03b2. Arterioscler Thromb Vasc Biol. 2012;32(9):2232\u201340.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6595","key":"308_CR46","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/383073a0","volume":"383","author":"P Carmeliet","year":"1996","unstructured":"Carmeliet P, Mackman N, Moons L, Luther T, Gressens P, Van Vlaenderen L, et al. Role of tissue factor in embryonic blood vessel development. Nature. 1996;383(6595):73\u20135.","journal-title":"Nature"},{"issue":"7","key":"308_CR47","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1182\/blood-2004-09-3567","volume":"105","author":"S Butenas","year":"2005","unstructured":"Butenas S, Bouchard BA, Brummel-Ziedins KE, Parhami-Seren B, Mann KG. Tissue factor activity in whole blood. Blood. 2005;105(7):2764\u201370.","journal-title":"Blood"},{"issue":"1","key":"308_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-8722-5-16","volume":"5","author":"C Hu","year":"2012","unstructured":"Hu C, Huang L, Gest C, Xi X, Janin A, Soria C, et al. Opposite regulation by PI3K\/Akt and MAPK\/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells. J Hematol Oncol. 2012;5(1):1\u201310.","journal-title":"J Hematol Oncol"},{"issue":"15","key":"308_CR49","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1161\/01.CIR.0000015465.73933.3B","volume":"105","author":"M Eto","year":"2002","unstructured":"Eto M, Kozai T, Cosentino F, Joch H, L\u00fcscher TF. Statin prevents tissue factor expression in human endothelial cells: role of Rho\/Rho-kinase and Akt pathways. Circulation. 2002;105(15):1756\u20139.","journal-title":"Circulation"},{"issue":"6","key":"308_CR50","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1158\/0008-5472.CAN-08-1547","volume":"69","author":"Y Rong","year":"2009","unstructured":"Rong Y, Belozerov VE, Tucker-Burden C, Chen G, Durden DL, Olson JJ, et al. Epidermal growth factor receptor and PTEN modulate tissue factor expression in glioblastoma through JunD\/activator protein-1 transcriptional activity. Can Res. 2009;69(6):2540\u20139.","journal-title":"Can Res"},{"key":"308_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/326041","volume":"213","author":"C-Y Huang","year":"2013","unstructured":"Huang C-Y, Lin H-J, Chen H-S, Cheng S-Y, Hsu H-C, Tang C-H. Thrombin promotes matrix metalloproteinase-13 expression through the PKC\u03b4\/c-Src\/EGFR\/PI3K\/Akt\/AP-1 signaling pathway in human chondrocytes. Mediators Inflamm. 2013;213:1.","journal-title":"Mediators Inflamm."},{"issue":"1","key":"308_CR52","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3746\/pnf.2019.24.1.56","volume":"24","author":"H-W Kwon","year":"2019","unstructured":"Kwon H-W. Inhibitory effects of ginsenoside Ro on clot retraction through suppressing PI3K\/Akt signaling pathway in human platelets. Prev Nutr Food Sci. 2019;24(1):56.","journal-title":"Prev Nutr Food Sci"},{"key":"308_CR53","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V122.21.3513.3513","volume-title":"Targeting the PI3K\/AKT pathway to inhibit platelet activation and thrombus formation","author":"W Yi","year":"2013","unstructured":"Yi W, Li W, Ren L, Mao X, Zhu L. Targeting the PI3K\/AKT pathway to inhibit platelet activation and thrombus formation. Washington DC: American Society of Hematology Washington; 2013."},{"key":"308_CR54","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bone.2015.10.005","volume":"83","author":"N Sato","year":"2016","unstructured":"Sato N, Ichikawa J, Wako M, Ohba T, Saito M, Sato H, et al. Thrombin induced by the extrinsic pathway and PAR-1 regulated inflammation at the site of fracture repair. Bone. 2016;83:23\u201334.","journal-title":"Bone"},{"issue":"8","key":"308_CR55","doi-asserted-by":"publisher","first-page":"e0182374","DOI":"10.1371\/journal.pone.0182374","volume":"12","author":"CN de la Pe\u00f1a","year":"2017","unstructured":"de la Pe\u00f1a CN, Gutierrez-Aguilar M, Hernandez-Resendiz I, Marin-Hernandez A, Rodriguez-Enriquez S. Glycoprotein Ib activation by thrombin stimulates the energy metabolism in human platelets. PLoS One. 2017;12(8):e0182374.","journal-title":"PLoS One."},{"key":"308_CR56","doi-asserted-by":"publisher","first-page":"111564","DOI":"10.1016\/j.biopha.2021.111564","volume":"139","author":"MR Khezri","year":"2021","unstructured":"Khezri MR, Yousefi K, Ghasemnejad-Berenji M. Angiotensin II: a possible target for therapeutic intervention in COVID-19. Biomed Pharmacother Biomed Pharmacother. 2021;139:111564.","journal-title":"Biomed Pharmacother Biomed Pharmacother."},{"issue":"02","key":"308_CR57","doi-asserted-by":"publisher","first-page":"e138","DOI":"10.1055\/s-0040-1713678","volume":"4","author":"W Miesbach","year":"2020","unstructured":"Miesbach W. Pathological role of angiotensin II in severe COVID-19. TH open. 2020;4(02):e138\u201344.","journal-title":"TH open"},{"issue":"6","key":"308_CR58","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1161\/HYPERTENSIONAHA.110.158220","volume":"56","author":"EY Senchenkova","year":"2010","unstructured":"Senchenkova EY, Russell J, Almeida-Paula LD, Harding JW, Granger DN. Angiotensin II\u2013mediated microvascular thrombosis. Hypertension. 2010;56(6):1089\u201395.","journal-title":"Hypertension"},{"issue":"5","key":"308_CR59","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/S0306-3623(97)00021-9","volume":"29","author":"ME Pueyo","year":"1997","unstructured":"Pueyo ME, Michel J-B. Angiotensin II receptors in endothelial cells. General Pharmacol Vasc Syst. 1997;29(5):691\u20136.","journal-title":"General Pharmacol Vasc Syst"},{"issue":"2","key":"308_CR60","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1161\/01.RES.86.2.139","volume":"86","author":"E Napoleone","year":"2000","unstructured":"Napoleone E, Di Santo A, Camera M, Tremoli E, Lorenzet R. Angiotensin-converting enzyme inhibitors downregulate tissue factor synthesis in monocytes. Circ Res. 2000;86(2):139\u201343.","journal-title":"Circ Res"},{"issue":"6","key":"308_CR61","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s10557-013-6471-z","volume":"27","author":"L-X Jia","year":"2013","unstructured":"Jia L-X, Qi G-M, Liu O, Li T-T, Yang M, Cui W, et al. Inhibition of platelet activation by clopidogrel prevents hypertension-induced cardiac inflammation and fibrosis. Cardiovasc Drugs Ther. 2013;27(6):521\u201330.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"3","key":"308_CR62","first-page":"S251","volume":"3","author":"Y-A Ding","year":"1985","unstructured":"Ding Y-A, MacIntyre D, Kenyon C, Semple P. Angiotensin II effects on platelet function. J Hypertension Suppl. 1985;3(3):S251\u20133.","journal-title":"J Hypertension Suppl"},{"issue":"1","key":"308_CR63","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.atherosclerosis.2004.07.008","volume":"177","author":"KK Koh","year":"2004","unstructured":"Koh KK, Chung W-J, Ahn JY, Han SH, Kang WC, Seo Y-H, et al. Angiotensin II type 1 receptor blockers reduce tissue factor activity and plasminogen activator inhibitor type-1 antigen in hypertensive patients: a randomized, double-blind, placebo-controlled study. Atherosclerosis. 2004;177(1):155\u201360.","journal-title":"Atherosclerosis"},{"issue":"6\u20137","key":"308_CR64","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.placenta.2005.07.001","volume":"27","author":"S Ishimatsu","year":"2006","unstructured":"Ishimatsu S, Itakura A, Okada M, Kotani T, Iwase A, Kajiyama H, et al. Angiotensin II augmented migration and invasion of choriocarcinoma cells involves PI3K activation through the AT1 receptor. Placenta. 2006;27(6\u20137):587\u201391.","journal-title":"Placenta"},{"issue":"5","key":"308_CR65","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.thromres.2005.04.033","volume":"117","author":"M He","year":"2006","unstructured":"He M, He X, Xie Q, Chen F, He S. Angiotensin II induces the expression of tissue factor and its mechanism in human monocytes. Thromb Res. 2006;117(5):579\u201390.","journal-title":"Thromb Res"},{"issue":"4","key":"308_CR66","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0049-3848(03)00346-3","volume":"110","author":"Y Kunieda","year":"2003","unstructured":"Kunieda Y, Nakagawa K, Nishimura H, Kato H, Ukimura N, Yano S, et al. HMG CoA reductase inhibitor suppresses the expression of tissue factor and plasminogen activator inhibitor-1 induced by angiotensin II in cultured rat aortic endothelial cells. Thromb Res. 2003;110(4):227\u201334.","journal-title":"Thromb Res"},{"key":"308_CR67","doi-asserted-by":"publisher","first-page":"32188","DOI":"10.1038\/srep32188","volume":"6","author":"J Bester","year":"2016","unstructured":"Bester J, Pretorius E. Effects of IL-1\u03b2, IL-6 and IL-8 on erythrocytes, platelets and clot viscoelasticity. Sci Rep. 2016;6:32188.","journal-title":"Sci Rep"},{"issue":"2","key":"308_CR68","doi-asserted-by":"publisher","first-page":"e12291","DOI":"10.1111\/xen.12291","volume":"24","author":"H Gao","year":"2017","unstructured":"Gao H, Liu L, Zhao Y, Hara H, Chen P, Xu J, et al. Human IL-6, IL-17, IL-1\u03b2, and TNF-\u03b1 differently regulate the expression of pro-inflammatory related genes, tissue factor, and swine leukocyte antigen class I in porcine aortic endothelial cells. Xenotransplantation. 2017;24(2):e12291.","journal-title":"Xenotransplantation."},{"issue":"1","key":"308_CR69","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12964-018-0268-4","volume":"16","author":"MM Zegeye","year":"2018","unstructured":"Zegeye MM, Lindkvist M, F\u00e4lker K, Kumawat AK, Paramel G, Greneg\u00e5rd M, et al. Activation of the JAK\/STAT3 and PI3K\/AKT pathways are crucial for IL-6 trans-signaling-mediated pro-inflammatory response in human vascular endothelial cells. Cell Commun Signal. 2018;16(1):55.","journal-title":"Cell Commun Signal"},{"issue":"4","key":"308_CR70","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/cvr\/cvw162","volume":"111","author":"A Anselmo","year":"2016","unstructured":"Anselmo A, Riva F, Gentile S, Soldani C, Barbagallo M, Mazzon C, et al. Expression and function of IL-1R8 (TIR8\/SIGIRR): a regulatory member of the IL-1 receptor family in platelets. Cardiovasc Res. 2016;111(4):373\u201384.","journal-title":"Cardiovasc Res"},{"issue":"5\u20136","key":"308_CR71","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1159\/000460254","volume":"23","author":"Z Xiao","year":"2016","unstructured":"Xiao Z, Peng J, Gan N, Arafat A, Yin F. Interleukin-1\u03b2 plays a pivotal role via the PI3K\/Akt\/mTOR signaling pathway in the chronicity of mesial temporal lobe epilepsy. NeuroImmunoModulation. 2016;23(5\u20136):332\u201344.","journal-title":"NeuroImmunoModulation"},{"issue":"3","key":"308_CR72","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1161\/ATVBAHA.113.302700","volume":"34","author":"LM Beaulieu","year":"2014","unstructured":"Beaulieu LM, Lin E, Mick E, Koupenova M, Weinberg EO, Kramer CD, et al. Interleukin 1 receptor 1 and interleukin 1\u03b2 regulate megakaryocyte maturation, platelet activation, and transcript profile during inflammation in mice and humans. Arterioscler Thromb Vasc Biol. 2014;34(3):552\u201364.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"308_CR73","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1096\/fj.00-0247com","volume":"15","author":"D Mechtcheriakova","year":"2001","unstructured":"Mechtcheriakova D, Schabbauer G, Lucerna M, Clauss M, De Martin R, Binder BR, et al. Specificity, diversity, and convergence in VEGF and TNF-alpha signaling events leading to tissue factor up-regulation via EGR-1 in endothelial cells. Faseb j. 2001;15(1):230\u201342.","journal-title":"Faseb j"},{"issue":"5","key":"308_CR74","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1165\/rcmb.2012-0097OC","volume":"47","author":"M Wygrecka","year":"2012","unstructured":"Wygrecka M, Zakrzewicz D, Taborski B, Didiasova M, Kwapiszewska G, Preissner KT, et al. TGF-\u03b21 induces tissue factor expression in human lung fibroblasts in a PI3K\/JNK\/Akt-dependent and AP-1-dependent manner. Am J Respir Cell Mol Biol. 2012;47(5):614\u201327.","journal-title":"Am J Respir Cell Mol Biol"}],"container-title":["Cellular &amp; Molecular Biology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-022-00308-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11658-022-00308-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-022-00308-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T17:46:25Z","timestamp":1700070385000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmbl.biomedcentral.com\/articles\/10.1186\/s11658-022-00308-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,11]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["308"],"URL":"https:\/\/doi.org\/10.1186\/s11658-022-00308-w","relation":{},"ISSN":["1425-8153","1689-1392"],"issn-type":[{"value":"1425-8153","type":"print"},{"value":"1689-1392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,11]]},"assertion":[{"value":"19 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There are no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}